Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6

Cell Death and Disease

Volumn 6, Issue 3, 2015, Pages

  Schull S ^a   Gunther S D ^a   Brodesser, S ^a   Seeger, J M ^a   Tosetti, B ^a   Wiegmann, K ^a   Pongratz, C ^a   Diaz, F ^b   Witt, A ^a   Andree, M ^a   Brinkmann, K ^a   Kronke M ^a   Wiesner, R J ^a   Kashkar, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERS6 PROTEIN, HUMAN; CYTOCHROME C OXIDASE; MEMBRANE PROTEIN; SPHINGOSINE ACYLTRANSFERASE;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; CYTOCHROME C OXIDASE DEFICIENCY; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; MITOCHONDRION; MOUSE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOLOGY;

ANIMALS; APOPTOSIS; CYTOCHROME-C OXIDASE DEFICIENCY; ELECTRON TRANSPORT COMPLEX IV; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; OXIDATIVE STRESS; OXYGEN CONSUMPTION; SPHINGOSINE N-ACYLTRANSFERASE;

EID: 84965087277     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/CDDIS.2015.62     Document Type: Article

References (61)

1. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 1961; 191: 144–148.
2. Breuer ME, Koopman WJ, Koene S, Nooteboom M, Rodenburg RJ, Willems PH et al. The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases. Neurobiol Dis 2013; 51: 27–34.
3. Wallace DC, Fan W. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev 2009; 23: 1714–1736.
4. Fuentes-Prior P, Salvesen GS. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004; 384: 201–232.
5. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675–1687.
6. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47–59.
7. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489.
8. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K et al. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8A. Science 1996; 272: 1136–1144.
9. von Kleist-Retzow JC, Hornig-Do HT, Schauen M, Eckertz S, Dinh TA, Stassen F et al. Impaired mitochondrial Ca2+ homeostasis in respiratory chain-deficient cells but efficient compensation of energetic disadvantage by enhanced anaerobic glycolysis due to low ATP steady state levels. Exp Cell Res 2007; 313: 3076–3089.
10. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813–824.
11. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012; 48: 158–167.
12. Bruno C, Martinuzzi A, Tang Y, Andreu AL, Pallotti F, Bonilla E et al. A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV. Am J Hum Genet 1999; 65: 611–620.
13. Diaz F, Fukui H, Garcia S, Moraes CT. Cytochrome c oxidase is required for the assembly/ stability of respiratory complex I in mouse fibroblasts. Mol Cell Biol 2006; 26: 4872–4881.
14. Brinkmann K, Kashkar H. Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies? Cell Death Dis 2014; 5: e1098.
15. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727–730.
16. Seeger JM, Brinkmann K, Yazdanpanah B, Haubert D, Pongratz C, Coutelle O et al. Elevated XIAP expression alone does not confer chemoresistance. Br J Cancer 2010; 102: 1717–1723.
17. Diaz F, Garcia S, Padgett KR, Moraes CT. A defect in the mitochondrial complex III, but not complex IV, triggers early ROS-dependent damage in defined brain regions. Hum Mol Genet 2012; 21: 5066–5077.
18. Crimi M, Esposti MD. Apoptosis-induced changes in mitochondrial lipids. Biochim Biophys Acta 2011; 1813: 551–557.
19. Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ et al. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 2012; 148: 988–1000.
20. Jin J, Hou Q, Mullen TD, Zeidan YH, Bielawski J, Kraveka JM et al. Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells. J Biol Chem 2008; 283: 26509–26517.
21. Kashkar H, Wiegmann K, Yazdanpanah B, Haubert D, Kronke M. Acid sphingomyelinase is indispensable for UV light-induced Bax conformational change at the mitochondrial membrane. J Biol Chem 2005; 280: 20804–20813.
22. Lee H, Rotolo JA, Mesicek J, Penate-Medina T, Rimner A, Liao WC et al. Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PloS One 2011; 6: e19783.
23. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993; 259: 1769–1771.
24. Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature 2014; 510: 58–67.
25. Mullen TD, Hannun YA, Obeid LM. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem J 2012; 441: 789–802.
26. Siskind LJ, Mullen TD, Romero Rosales K, Clarke CJ, Hernandez-Corbacho MJ, Edinger AL et al. The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis. J Biol Chem 2010; 285: 11818–11826.
27. Siskind LJ, Kolesnick RN, Colombini M. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 2006; 6: 118–125.
28. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH Jr. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 1991; 266: 14486–14490.
29. Futerman AH, Riezman H. The ins and outs of sphingolipid synthesis. Trends Cell Biol 2005; 15: 312–318.
30. Novgorodov SA, Chudakova DA, Wheeler BW, Bielawski J, Kindy MS, Obeid LM et al. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis. J Biol Chem 2011; 286: 4644–4658.
31. White-Gilbertson S, Mullen T, Senkal C, Lu P, Ogretmen B, Obeid L et al. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 2009; 28: 1132–1141.
32. Mesika A, Ben-Dor S, Laviad EL, Futerman AH. A new functional motif in Hox domain-containing ceramide synthases: identification of a novel region flanking the Hox and TLC domains essential for activity. J Biol Chem 2007; 282: 27366–27373.
33. Lahiri S, Futerman AH. LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J Biol Chem 2005; 280: 33735–33738.
34. Riebeling C, Allegood JC, Wang E, Merrill AH Jr, Futerman AH. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem 2003; 278: 43452–43459.
35. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995; 11: 144–149.
36. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242:1427–1430.
37. Ylikallio E, Suomalainen A. Mechanisms of mitochondrial diseases. Ann Med 2012; 44: 41–59.
38. Diaz F, Garcia S, Hernandez D, Regev A, Rebelo A, Oca-Cossio J et al. Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Gut 2008; 57: 232–242.
39. Diaz F, Thomas CK, Garcia S, Hernandez D, Moraes CT. Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency. Hum Mol Genet 2005; 14: 2737–2748.
40. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298–300.
41. Sastre J, Pallardo FV, Vina J. Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life 2000; 49: 427–435.
42. Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc 1972; 20: 145–147.
43. Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan 2014; 3: 6.
44. D'Mello NP, Childress AM, Franklin DS, Kale SP, Pinswasdi C, Jazwinski SM. Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J Biol Chem 1994; 269: 15451–15459.
45. Jiang JC, Kirchman PA, Zagulski M, Hunt J, Jazwinski SM. Homologs of the yeast longevity gene LAG1 in Caenorhabditis elegans and human. Genome Res 1998; 8: 1259–1272.
46. Guillas I, Kirchman PA, Chuard R, Pfefferli M, Jiang JC, Jazwinski SM et al. C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. EMBO J 2001; 20: 2655–2665.
47. Schorling S, Vallee B, Barz WP, Riezman H, Oesterhelt D. Lag1p and Lac1p are essential for the acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae. Mol Biol Cell 2001; 12: 3417–3427.
48. Park JW, Park WJ, Futerman AH. Ceramide synthases as potential targets for therapeutic intervention in human diseases. Biochim Biophys Acta 2014; 1841: 671–681.
49. Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V. Role of apoptosis in disease. Aging 2012; 4: 330–349.
50. Rohn TT, Vyas V, Hernandez-Estrada T, Nichol KE, Christie LA, Head E. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 2008; 28: 3051–3059.
51. Raichur S, Wang ST, Chan PW, Li Y, Ching J, Chaurasia B et al. CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 2014; 20: 687–695.
52. Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 2014; 20: 678–686.
53. Hornig-Do HT, Tatsuta T, Buckermann A, Bust M, Kollberg G, Rotig A et al. Nonsense mutations in the COX1 subunit impair the stability of respiratory chain complexes rather than their assembly. EMBO J 2012; 31: 1293–1307.
54. Coutelle O, Hornig-Do HT, Witt A, Andree M, Schiffmann LM, Piekarek M et al. Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing. EMBO Mol Med 2014; 6: 624–639.
55. Senkal CE, Ponnusamy S, Bielawski J, Hannun YA, Ogretmen B. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. FASEB J 2010; 24: 296–308.
56. Brinkmann K, Zigrino P, Witt A, Schell M, Ackermann L, Broxtermann P et al. Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA. Cell Rep 2013; 3: 881–891.
57. Kashkar H, Haefs C, Shin H, Hamilton-Dutoit SJ, Salvesen GS, Kronke M et al. XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells. J Exp Med 2003; 198: 341–347.
58. Kashkar H, Kronke M, Jurgensmeier JM. Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. Cell Death Differ 2002; 9: 750–757.
59. Schwamb J, Feldhaus V, Baumann M, Patz M, Brodesser S, Brinker R et al. B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood 2012; 120: 3978–3985.
60. Shaner RL, Allegood JC, Park H, Wang E, Kelly S, Haynes CA et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J Lipid Res 2009; 50: 1692–1707.
61. Andree M, Seeger JM, Schull S, Coutelle O, Wagner-Stippich D, Wiegmann K et al. BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J 2014; 33: 2171–2187.